Cabaletta Bio, Inc.

Analysis for Ticker: CABA

Cabaletta Bio Inc is a science experiment pretending to be a business by trying to fix the human immune system with expensive cell engineering. The math is a total disaster for anyone holding their paper because on 04/05/2026, the company flooded the market with 51.725.000 brand new shares at 2,90$ each just to keep the lights on. Even though they pulled 141$ million out of the market, they are burning money so fast that they admit it will all be gone by the middle of 2027. Think of it like a bucket with a massive hole; it does not matter how much water you pour in if the hole keeps getting bigger. On the day of this offering, the people buying these new shares instantly lost 1,30$ in real value the moment they handed over their money, as the actual value of the company assets per share is only 1,60$. The banks and middlemen, including TD Cowen and Guggenheim Securities, took 9.000.150$ in fees before the company even touched a cent, leaving regular investors to pay for a scientific gamble that is already running out of time.